Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies

Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies

COVID-19 (SARS-CoV-2) disease severity and stages varies from asymptomatic, mild flu-like symptoms, moderate, severe, critical, and chronic disease. COVID-19 disease progression include lymphopenia, elevated proinflammatory cytokines and chemokines, accumulation of macrophages and neutrophils in lun...

Full description

Bibliographic Details
Main Author:	Ricke, Darrell O.
Other Authors:	Lincoln Laboratory
Format:	Article
Published:	Frontiers Media 2021
Online Access:	https://hdl.handle.net/1721.1/130232

Similar Items

Development of human monoclonal antibodies against SARS-CoV-2
by: Wong, Joel Xu En
Published: (2021)

Compromised SARS-CoV-2-specific placental antibody transfer
by: Atyeo, Caroline, et al.
Published: (2021)

The Kinetics of SARS-CoV-2 Antibody Development Is Associated with Clearance of RNAemia
by: Wang, Chuangqi, et al.
Published: (2023)

Janus Emulsion Biosensors for Anti-SARS-CoV-2 Spike Antibody
by: Li, Jie, et al.
Published: (2022)

Discrete SARS-CoV-2 antibody titers track with functional humoral stability
by: Bartsch, Yannic C., et al.
Published: (2021)

Selective functional antibody transfer into the breastmilk after SARS-CoV-2 infection
by: Pullen, Krista M, et al.
Published: (2023)

An Antigenic Space Framework for Understanding Antibody Escape of SARS-CoV-2 Variants
by: Miller, Nathaniel L., et al.
Published: (2021)

Targeting the SARS-CoV-2-spike protein: from antibodies to miniproteins and peptides
by: Pomplun, Sebastian Johannes
Published: (2021)

Two-years antibody responses following SARS-CoV-2 infection in humans: A study protocol
by: Arguni, Eggi, et al.
Published: (2022)

Antibody screening at reduced pH enables preferential selection of potently neutralizing antibodies targeting SARS‐CoV ‐2
by: Madan, Bharat, et al.
Published: (2022)

Rapid quantification of SARS-CoV-2 neutralising antibodies using time- resolved fluorescence immunoassay
by: McLean, Gary R., et al.
Published: (2022)

Mapping monoclonal anti-SARS-CoV-2 antibody repertoires against diverse coronavirus antigens
by: DeKosky, Brandon J.
Published: (2022)

Models to inform neutralizing antibody therapy strategies during pandemics: the case of SARS-CoV-2
by: Guttieres, Donovan, et al.
Published: (2021)

Design of immunogens for eliciting antibody responses that may protect against SARS-CoV-2 variants
by: Wang, Eric, et al.
Published: (2022)

Analysis of surface expressed recombinant SARS-CoV-2 spike protein using human monoclonal antibodies
by: Wu, Yanjun
Published: (2024)

Deep learning guided optimization of human antibody against SARS-CoV-2 variants with broad neutralization
by: Shan, Sisi, et al.
Published: (2022)

Finger stick blood test to assess postvaccination SARS-CoV-2 neutralizing antibody response against variants
by: Lim, Sing Mei, et al.
Published: (2023)

Engineering SARS-CoV-2 specific cocktail antibodies into a bispecific format improves neutralizing potency and breadth
by: Ku, Zhiqiang, et al.
Published: (2023)

Graph convolutional network with self-attention pooling for the prediction of neutralizing paratope sequences of SARS-CoV2 antibodies
by: Rashid, Shamima, et al.
Published: (2024)

Direct capture of neutralized RBD enables rapid point-of-care assessment of SARS-CoV-2 neutralizing antibody titer
by: Connelly, Guinevere G, et al.
Published: (2023)

Hypertension is associated with antibody response and breakthrough infection in health care workers following vaccination with inactivated SARS-CoV-2
by: Soegiarto, Gatot, et al.
Published: (2022)

Examining the immunoreactivities of the receptor-binding domain of SARS-CoV-2 spike proteins using a panel of human monoclonal antibodies
by: Tan, Jie Ling
Published: (2022)

Antigen presentation dynamics shape the antibody response to variants like SARS-CoV-2 Omicron after multiple vaccinations with the original strain
by: Yang, Leerang, et al.
Published: (2024)

The SARS-CoV-2 variants and their impacts
by: Akmal Shukri, Amir Muhaimin, et al.
Published: (2022)

mRNA booster vaccination enhances antibody responses against SARS-CoV2 omicron variant in individuals primed with mRNA or inactivated virus vaccines
by: Zhang, Biyan, et al.
Published: (2022)

Evolution of enhanced innate immune evasion by SARS-CoV-2
by: Kellis, Manolis
Published: (2022)

Oligomerization-dependent beta-structure formation in SARS-CoV-2 envelope protein
by: Surya, Wahyu, et al.
Published: (2023)

Pathophysiology, histopathology and therapeutic of SARS-CoV-2
by: Noman, Efaq, et al.
Published: (2020)

Lateral flow immunoassays for SARS-CoV-2
by: Ang, Geik Yong, et al.
Published: (2022)

SARS-CoV-2-specific ELISA development
by: Roy, Vicky, et al.
Published: (2021)

Serological Markers of SARS-CoV-2 Reinfection
by: Lauffenburger, Douglas
Published: (2023)

The cellular characterization of SARS-CoV-2 spike protein in virus-infected cells using the receptor binding domain binding specific human monoclonal antibodies
by: Chan, Conrad En-Zuo, et al.
Published: (2022)

Employment of a high throughput functional assay to define the critical factors that influence vaccine induced cross-variant neutralizing antibodies for SARS-CoV-2
by: Gu, Yue, et al.
Published: (2024)

Orthogonal immunoassays for IgG antibodies to SARS-CoV-2 antigens reveal that immune response lasts beyond 4 mo post illness onset
by: Sasisekharan, Varun, et al.
Published: (2021)

Mechanistic insights of host cell fusion of SARS-CoV-1 and SARS-CoV-2 from atomic resolution structure and membrane dynamics
by: Chakraborty, Hirak, et al.
Published: (2021)

Decoding Covid-19 with the SARS-CoV-2 genome
by: Ellis, Phoebe, et al.
Published: (2021)

Development of SARS-CoV-2 Vaccine: Challenges and Prospects
by: Tooba Mahboob, et al.
Published: (2023)

Surveillance of SARS-CoV-2: From Sewage to the Clinic
by: Xiao, Amy
Published: (2023)

Epidemiological and Immunological Features of Obesity and SARS-CoV-2
by: Nilles, Eric J., et al.
Published: (2021)

Sampling manholes to home in on SARS-CoV-2 infections
by: Larson, Richard Charles, et al.
Published: (2020)